Vivos (RDGL) Debt Ratio (2010 - 2023)
Vivos (RDGL) posted Debt Ratio of 0.01 for Q3 2023, down 99.99% sequentially from 54.72 in Q1 2019.
Vivos (RDGL) Debt Ratio (2010 - 2023) Analysis & Trends
Vivos has reported Debt Ratio for 11 years, with the latest figure at 0.01 in Q3 2023.
- Quarterly Debt Ratio changed N/A year-over-year to 0.01 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was 0.01 (changed N/A YoY) and the FY2018 annual result came in at 190.25, changed N/A from the prior year.
- Debt Ratio fell to 0.01 in Q3 2023 per RDGL's latest filing, from 54.72 in the prior quarter.
- Over five years, Debt Ratio peaked at 54.72 in Q1 2019 and troughed at 0.01 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 0.30 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 0.31 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.28 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.04 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 0.27 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 0.28 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.18 |
| 10 | Vivos | 24.08 Mn | 22.53 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 0.01 |
| Mar 31, 2019 | 54.72 |
| Dec 31, 2018 | 190.25 |
| Sep 30, 2018 | 2.75 |
| Mar 31, 2018 | 58.39 |
| Sep 30, 2017 | 12.99 |
| Jun 30, 2017 | 1.02 |
| Mar 31, 2017 | 15.30 |
| Dec 31, 2016 | 7.91 |
| Sep 30, 2016 | 4.30 |
| Jun 30, 2016 | 4.30 |
| Mar 31, 2016 | 4.20 |
| Dec 31, 2015 | 5.04 |
| Sep 30, 2015 | 12.65 |
| Jun 30, 2015 | 43.84 |
| Mar 31, 2015 | 11.76 |
| Dec 31, 2014 | 49.27 |
| Sep 30, 2014 | 3.31 |
| Jun 30, 2014 | 1.88 |
| Mar 31, 2014 | 1.15 |